CymitQuimica logo

CAS 18179-67-4

:

Sulfamethoxydiazine

Description:
Sulfamethoxydiazine is a sulfonamide antibiotic that belongs to the class of sulfa drugs, which are characterized by their ability to inhibit bacterial growth by interfering with folic acid synthesis. This compound is typically used in veterinary medicine, particularly for the treatment of bacterial infections in livestock and poultry. It exhibits broad-spectrum antibacterial activity against various Gram-positive and Gram-negative bacteria. Sulfamethoxydiazine is known for its relatively low toxicity in animals, making it a preferred choice in veterinary applications. The compound is usually administered orally and is well-absorbed in the gastrointestinal tract. Its mechanism of action involves competitive inhibition of the enzyme dihydropteroate synthase, which is crucial for the synthesis of folate in bacteria. Additionally, sulfamethoxydiazine may have a long half-life, allowing for less frequent dosing. However, like other sulfonamides, it can cause adverse effects, including allergic reactions and potential impacts on gut flora. Proper dosage and monitoring are essential to minimize risks and ensure effective treatment.
Formula:C11H11N4NaO3S
InChI:InChI=1/C11H11N4O3S.Na/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10;/h2-7,12H,1H3,(H,13,14,15);/q-1;+1
Synonyms:
  • Sodium {4-[(5-Methoxypyrimidin-2-Yl)Sulfamoyl]Phenyl}Azanide
  • Sulfamethoxydiazine sodium
  • Sulpamethoxydiazine sodium
  • Sulfameter Sodium
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.